Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations
- Resource Type
- Journal
- Source
ONCOTARGET ; DEC 1 2017, 8 62, p105479-p105491, 13p.- Subject
- Language
- English
- ISSN
- 19492553